Real-World Patient Eligibility for Alzheimer's Disease Anti-Amyloid Therapy in Seven Swedish Memory Clinics. (PubMed, Eur J Neurol) - Oct 21, 2026 - "Even upper-bound estimates indicate that a minority of real-world memory clinic patients may currently qualify for anti-amyloid therapy. These findings provide timely evidence to inform the ongoing debate on the implementation of anti-amyloid therapy in public healthcare."
Journal • Real-world evidence • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia • Aβ42 • CSF Aβ42
|
|
Anette Hall; Anna Matton; Anna Rennie; Anna Rosenberg; Ari Solomon; Eric Westman; Lars-Olof Wahlund; Makrina Daniilidou; Miia Kivipelto; Urban Ekman
|